Two Sigma Securities’s Propanc Biopharma PPCB Stock Holding History

Two Sigma Securities’s Portfolio PPCB Stock Details PPCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,019	Closed	-$13.7K	–	2366
2025 Q4	$13.7K	Buy	+1,019	New	+$28.2K	﹤0.01%	1247

Other funds holding PPCB

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SCA

Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Two Sigma Securities's PPCB Position: Q1 2026 in Review

Two Sigma Securities sold out of Propanc Biopharma (PPCB) in Q1 2026, closing a stake of 1,019 shares — an estimated $13.7K sold.

Two Sigma Securities first reported a position in PPCB in Q4 2025 and held it in 1 quarter. The position peaked at $13.7K in Q4 2025. 6 funds tracked by Wall St. Rank hold PPCB as of Q1 2026.

Two Sigma Securities reported no remaining Propanc Biopharma position as of Q1 2026 after selling out during the quarter.
Two Sigma Securities sold 1,019 Propanc Biopharma shares in Q1 2026, an estimated $13.7K.
Two Sigma Securities first reported a position in Propanc Biopharma in Q4 2025 and held it in 1 quarter.
Two Sigma Securities's Propanc Biopharma position peaked at $13.7K in Q4 2025.
6 funds tracked by Wall St. Rank held Propanc Biopharma as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.